Introduction
While continuous positive airway pressure therapy and oral appliances represent the primary treatment modalities for obstructive sleep apnea, surgical intervention becomes relevant when patients are intolerant of or refuse non-surgical treatment, or when specific anatomical abnormalities amenable to surgical correction are identified. Surgical approaches to OSA have evolved from empirical procedures with modest efficacy to sophisticated techniques targeting identified anatomical obstruction sites.
Understanding available surgical options, anticipated efficacy, and associated complications enables appropriate surgical candidate selection and informed consent discussions. Modern surgical approaches frequently employ multilevel obstruction correction, recognizing that OSA typically involves obstruction at multiple anatomical sites rather than a single point of narrowing.
Uvulopalatopharyngoplasty (UPPP)
Uvulopalatopharyngoplasty represents one of the most extensively studied and widely performed surgical procedures for OSA. The procedure involves removal or modification of the soft palate, uvula, and redundant pharyngeal mucosa, with the goal of enlarging the oropharyngeal airway.
UPPP efficacy in reducing the apnea-hypopnea index varies considerably across studies, with meta-analyses demonstrating mean AHI reduction of 40-50% and complete response (AHI <5 events/hour) in only 30-40% of patients. This variable efficacy reflects heterogeneous patient populations, differing surgical techniques, and variable preoperative anatomical assessment.
UPPP demonstrates superior efficacy when performed on carefully selected patients with documented oropharyngeal obstruction and without retrognathic skeletal features or BMI >40 kg/m². Patients with primarily palatal obstruction demonstrate better outcomes than those with multilevel obstruction involving the tongue base.
Complications of UPPP include postoperative pain, difficulty swallowing, velopharyngeal insufficiency producing nasal regurgitation and hypernasal speech, and persistent snoring despite OSA improvement. Velopharyngeal insufficiency represents the most concerning complication, occurring in 5-15% of patients and sometimes requiring surgical correction or prosthetic management.
Long-term efficacy studies demonstrate variable treatment effects, with some patients experiencing gradual recurrence of apneic events over years following UPPP. These findings suggest that UPPP should be viewed as part of comprehensive OSA management rather than a definitive cure.
Genioglossus Advancement (GA)
Genioglossus advancement procedures address obstruction at the level of the tongue base by advancing the anterior mandible. The procedure involves partial division and anterior advancement of the genioglossus muscle and its osseous attachment, anchoring the tongue in an anteriorly positioned configuration.
GA procedures address tongue base obstruction without the speech and swallowing complications of UPPP. Efficacy studies demonstrate mean AHI reduction of 35-50%, with variable response patterns. GA demonstrates particular utility as a component of multilevel surgical approaches.
Genioglossus advancement preserves normal pharyngeal function while mechanically enlarging the retrolingual airway. The procedure requires careful surgical technique to prevent excessive mandibular division and complications including nonunion or malunion.
Complications of GA remain relatively uncommon but include permanent chin numbness, excessive advancement producing anterior open bite, and rare genioglossus re-displacement. Long-term outcomes generally remain stable without progressive efficacy loss, making GA a durable surgical intervention.
Maxillomandibular Advancement (MMA)
Maxillomandibular advancement represents the most effective surgical approach to OSA, involving simultaneous anterior advancement of both the maxilla and mandible. The procedure surgically relocates the jaw and associated soft tissue structures, substantially enlarging the oropharyngeal airway.
MMA produces remarkable efficacy, with meta-analyses demonstrating mean AHI reductions exceeding 75% and complete response rates of 60-80%. These outcomes substantially exceed those of other individual surgical procedures and approach the efficacy of CPAP therapy.
The mechanism underlying MMA efficacy involves enlargement of multiple anatomical compartments. Maxillary advancement increases the cross-sectional area of the nasal and oropharyngeal passages. Mandibular advancement repositions the tongue anteriorly, increasing retrolingual airway dimensions. The combined effect produces substantial improvements in airway collapsibility.
MMA requires careful patient selection, surgical expertise, and experience with orthognathic procedures. Ideal candidates include patients with skeletal Class II malocclusion, retrognathia, and documented OSA with failed non-surgical treatment. The procedure is typically reserved for carefully selected patients given the surgical magnitude and long-term occlusal implications.
Complications of MMA include infection, bleeding, relapse of skeletal advancement over time, and occlusal changes. Most complications remain manageable with appropriate surgical technique and postoperative care. Long-term occlusal stability is generally excellent, though modest relapse occurs in some patients.
Hypoglossal Nerve Stimulation (HGNS)
Hypoglossal nerve stimulation represents a novel neurostimulation approach to OSA treatment. The system comprises an implanted pulse generator placed subcutaneously in the chest wall, connected to a sensing lead placed around the hypoglossal nerve in the neck.
The device detects respiratory effort during sleep through impedance sensing. When inspiration is detected, the hypoglossal nerve receives electrical stimulation, activating the genioglossus and other tongue protrusor muscles, thereby advancing the tongue and enlarging the oropharyngeal airway. This dynamic repositioning maintains airway patency throughout sleep.
Clinical trials demonstrate HGNS efficacy with mean AHI reductions of 50-75% and complete response in approximately 50% of implanted patients. The therapy avoids the surgical anatomical changes of MMA while providing dynamic airway support throughout sleep.
HGNS represents a reversible intervention, as device removal restores baseline anatomy and OSA status. This reversibility, combined with the dynamic nature of airway support and preservation of normal swallowing and speech, make HGNS attractive for appropriately selected patients.
Ideal HGNS candidates include patients with moderate-to-severe OSA, failed or intolerant of CPAP, non-apneic obstructive pattern, and adequate anatomy without severe retrognathia. Contraindications include complete concentric collapse and severe anatomical obstruction.
Complications of HGNS include minor procedural risks, device-related infections, and need for periodic device adjustments and battery replacement. Long-term efficacy appears durable with sustained treatment response over 5+ years of follow-up in most patients.
Tonsillectomy and Adenoidectomy
Tonsillar and adenoidal hypertrophy represent significant OSA contributors, particularly in pediatric populations. Surgical removal of enlarged tonsils and adenoids can substantially reduce airway obstruction.
Tonsillectomy with or without adenoidectomy demonstrates efficacy in carefully selected adult patients with documented tonsillar hypertrophy. However, efficacy in adults is generally lower than in children and remains variable. Most adult OSA involves multifactorial obstruction with skeletal, soft tissue, and neuromuscular components, such that isolated tonsillar removal frequently fails to achieve complete symptom resolution.
The procedure maintains utility for adult patients with significant tonsillar enlargement contributing to demonstrated oropharyngeal obstruction.
Multilevel and Combination Surgical Approaches
Contemporary surgical management of OSA increasingly employs multilevel approaches addressing obstruction at multiple anatomical sites. Combining procedures such as UPPP, GA, and sometimes nasal procedures addresses the multiple anatomical factors typically contributing to OSA.
Multilevel surgery demonstrates superior efficacy compared to single procedures, with mean AHI reductions of 60-75% and complete response in 40-60% of properly selected patients. The approach requires comprehensive preoperative assessment to identify obstruction sites and careful surgical planning.
Surgical Candidate Selection and Outcomes
Successful surgical management of OSA requires comprehensive patient assessment, detailed anatomical evaluation, discussion of expected outcomes and risks, and realistic patient expectations. Patients should understand that surgical intervention may not completely resolve OSA and that complementary treatment modalities may ultimately be necessary.
Contraindications to elective surgical intervention include severe obesity limiting surgical safety, severe OSA with life-threatening hypoxemia during diagnostic testing, patient inability to comply with postoperative care, and active substance abuse.
Conclusion
Surgical management of obstructive sleep apnea offers important treatment options for selected patients. Maxillomandibular advancement demonstrates the highest efficacy, while hypoglossal nerve stimulation provides a novel dynamic approach. Careful patient selection, comprehensive anatomical assessment, and realistic outcome expectations optimize surgical success. Surgical intervention should be integrated into comprehensive OSA management rather than viewed as a standalone cure, recognizing that many patients ultimately require combination treatment modalities.